Is Cardio Diagnostics Stock a Good Investment?
Cardio Diagnostics Investment Advice | CDIOW |
- Examine Cardio Diagnostics' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Cardio Diagnostics' leadership team and their track record. Good management can help Cardio Diagnostics navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Cardio Diagnostics' business and its evolving consumer preferences.
- Compare Cardio Diagnostics' performance and market position to its competitors. Analyze how Cardio Diagnostics is positioned in terms of product offerings, innovation, and market share.
- Check if Cardio Diagnostics pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Cardio Diagnostics' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Cardio Diagnostics Holdings stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Cardio Diagnostics Holdings is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Cardio Diagnostics Stock
Researching Cardio Diagnostics' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company had not issued any dividends in recent years.
To determine if Cardio Diagnostics is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Cardio Diagnostics' research are outlined below:
| Cardio Diagnostics is way too risky over 90 days horizon | |
| Cardio Diagnostics has some characteristics of a very speculative penny stock | |
| Cardio Diagnostics appears to be risky and price may revert if volatility continues | |
| Cardio Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 17.07 K. Net Loss for the year was (8.38 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Cardio Diagnostics generates negative cash flow from operations | |
| Cardio Diagnostics has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Cardio Diagnostics shareholders approve key proposals - Investing.com |
Cardio Diagnostics' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (2.13) | (2.24) | |
| Return On Capital Employed | (2.00) | (2.10) | |
| Return On Assets | (1.88) | (1.97) | |
| Return On Equity | (2.83) | (2.97) |
Determining Cardio Diagnostics' profitability involves analyzing its financial statements and using various financial metrics to determine if Cardio Diagnostics is a good buy. For example, gross profit margin measures Cardio Diagnostics' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Cardio Diagnostics' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Cardio Diagnostics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Cardio Diagnostics Holdings. Check Cardio Diagnostics' Beneish M Score to see the likelihood of Cardio Diagnostics' management manipulating its earnings.
Evaluate Cardio Diagnostics' management efficiency
The company has return on total asset (ROA) of (0.9795) % which means that it has lost $0.9795 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.9327) %, meaning that it generated substantial loss on money invested by shareholders. Cardio Diagnostics' management efficiency ratios could be used to measure how well Cardio Diagnostics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -2.24 in 2024. Return On Capital Employed is likely to drop to -2.1 in 2024. At this time, Cardio Diagnostics' Non Current Assets Total are fairly stable compared to the past year. Debt To Assets is likely to climb to 0.12 in 2024, whereas Other Current Assets are likely to drop slightly above 974.7 K in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.23 | 0.22 | |
| Tangible Book Value Per Share | 0.19 | 0.18 | |
| Enterprise Value Over EBITDA | (20.63) | (21.66) | |
| Price Book Value Ratio | 10.68 | 10.14 | |
| Enterprise Value Multiple | (20.63) | (21.66) | |
| Price Fair Value | 10.68 | 10.14 | |
| Enterprise Value | 31.6 M | 37.3 M |
The management team at Cardio Diagnostics has a track record of steering the company towards sustained growth. Evaluating their strategies helps in understanding the stock's long-term potential.
Beta 4.679 |
Basic technical analysis of Cardio Stock
As of the 29th of November, Cardio Diagnostics shows the Downside Deviation of 16.27, risk adjusted performance of 0.047, and Mean Deviation of 12.09. Cardio Diagnostics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Cardio Diagnostics standard deviation, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if Cardio Diagnostics is priced correctly, providing market reflects its regular price of 0.03 per share. As Cardio Diagnostics appears to be a penny stock we also recommend to validate its total risk alpha numbers.Cardio Diagnostics' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cardio Diagnostics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cardio Diagnostics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cardio Diagnostics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Levy Oded over three weeks ago Disposition of tradable shares by Levy Oded of Cardio Diagnostics subject to Rule 16b-3 | ||
Philibert Robert over two months ago Acquisition by Philibert Robert of 16000 shares of Cardio Diagnostics at 0.6 subject to Rule 16b-3 | ||
Sim Brandon over three months ago Acquisition by Sim Brandon of tradable shares of Cardio Diagnostics subject to Rule 16b-3 |
Understand Cardio Diagnostics' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Cardio Diagnostics' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.047 | |||
| Market Risk Adjusted Performance | 0.2528 | |||
| Mean Deviation | 12.09 | |||
| Semi Deviation | 13.33 | |||
| Downside Deviation | 16.27 | |||
| Coefficient Of Variation | 2045.08 | |||
| Standard Deviation | 17.64 | |||
| Variance | 311.02 | |||
| Information Ratio | 0.0418 | |||
| Jensen Alpha | 0.4472 | |||
| Total Risk Alpha | (1.80) | |||
| Sortino Ratio | 0.0453 | |||
| Treynor Ratio | 0.2428 | |||
| Maximum Drawdown | 76.02 | |||
| Value At Risk | (26.57) | |||
| Potential Upside | 32.01 | |||
| Downside Variance | 264.87 | |||
| Semi Variance | 177.76 | |||
| Expected Short fall | (17.44) | |||
| Skewness | 0.6557 | |||
| Kurtosis | 1.18 |
| Risk Adjusted Performance | 0.047 | |||
| Market Risk Adjusted Performance | 0.2528 | |||
| Mean Deviation | 12.09 | |||
| Semi Deviation | 13.33 | |||
| Downside Deviation | 16.27 | |||
| Coefficient Of Variation | 2045.08 | |||
| Standard Deviation | 17.64 | |||
| Variance | 311.02 | |||
| Information Ratio | 0.0418 | |||
| Jensen Alpha | 0.4472 | |||
| Total Risk Alpha | (1.80) | |||
| Sortino Ratio | 0.0453 | |||
| Treynor Ratio | 0.2428 | |||
| Maximum Drawdown | 76.02 | |||
| Value At Risk | (26.57) | |||
| Potential Upside | 32.01 | |||
| Downside Variance | 264.87 | |||
| Semi Variance | 177.76 | |||
| Expected Short fall | (17.44) | |||
| Skewness | 0.6557 | |||
| Kurtosis | 1.18 |
Consider Cardio Diagnostics' intraday indicators
Cardio Diagnostics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Cardio Diagnostics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.77 | |||
| Day Median Price | 0.03 | |||
| Day Typical Price | 0.03 | |||
| Price Action Indicator | (0) | |||
| Period Momentum Indicator | (0.01) |
Cardio Stock media impact
Far too much social signal, news, headlines, and media speculation about Cardio Diagnostics that are available to investors today. That information is available publicly through Cardio media outlets and privately through word of mouth or via Cardio internal channels. However, regardless of the origin, that massive amount of Cardio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Cardio Diagnostics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cardio Diagnostics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cardio Diagnostics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cardio Diagnostics alpha.
Cardio Diagnostics Corporate Management
| Esq JD | Chief Officer | Profile | |
| Timur Dogan | Chief Officer | Profile | |
| Khullani JD | Vice Strategy | Profile | |
| MBA JD | CFO Director | Profile | |
| Khullani Abdullah | VP Strategy | Profile |
Additional Tools for Cardio Stock Analysis
When running Cardio Diagnostics' price analysis, check to measure Cardio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardio Diagnostics is operating at the current time. Most of Cardio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Cardio Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardio Diagnostics' price. Additionally, you may evaluate how the addition of Cardio Diagnostics to your portfolios can decrease your overall portfolio volatility.